After Scott Gottlieb, MD, steps down as commissioner of the FDA April 5, he will head back to the American Enterprise Institute to tackle the rising cost of prescription drugs, according to The Washington Post.
The 46-year-old physician, millionaire venture capitalist and cancer survivor plans to spend about a half-dozen days a month as a resident fellow at the conservative think tank. Before becoming FDA commissioner, Dr. Gottlieb wrote op-eds for the institute.
He announced in March he was leaving his position at the FDA to spend more time with his family. He had been commuting to Washington, D.C., from Connecticut weekly since his May 2017 appointment.
Beyond his work with the institute, Dr. Gottlieb plans to explore other opportunities, but "I don't know what they are right now," he told The Post.